Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery

BACKGROUND AND AIMS: Bariatric and metabolic surgery (BMS) may adversely affect noninvasive stool tests for colorectal cancer (CRC) screening through several mechanisms. Multitarget stool DNA (mt-sDNA) is approved for CRC screening; however, performance in post-BMS patients is unknown. As the rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebner, Derek W., Burger, Kelli N., Broderick, Brendan, Mahoney, Douglas W., Kellogg, Todd A., Acosta, Andres, Kisiel, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597571/
https://www.ncbi.nlm.nih.gov/pubmed/37876832
http://dx.doi.org/10.1016/j.gastha.2023.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597571/
https://www.ncbi.nlm.nih.gov/pubmed/37876832
http://dx.doi.org/10.1016/j.gastha.2023.06.005

Ejemplares similares